Biosimilars & Follow-on Biologics 2017 Americas

Paradigm Global Events is again proud to present it’s bi-annual Biosimilars & Follow-On Biologics 2017 Americas congress. In this congress, we will cover a diverse range of topic and address the challenges and obstacle encountered by the industry from development to successful market of biosimilars. This will also offer and provide a unique platform for knowledge sharing and convergence from Pharmaceuticals, Biotechnology, Regulatory and many more.

Gain Latest Insights On:

Learn the current global regulatory guidelines and considerations for developing and bringing the next generation of Biosimilars to the market
Know the strategies in place in developing and manufacturing biosimilars in emerging markets
Emerging Markets: Challenges and Benefits in Investing in Emerging Markets
Establishing and integration of biosimilarity and comparability into developing Biosimilars
Identify challenges encountered with Extrapolations and interchangeability, assessing immunogenicity and Pharmacovigilance
Explore CMC regulatory challenges and considerations for Biosimilars drug development and manufacturing
Study the pre-clinical and clinical challenges associated with the development of biosimilars
The importance of establishing partnerships and successful collaboration for Biosimilars business
Learn the latest updates, trends and current Biosimilars market situations in different regions
What does the future hold for Biosimilars and Biologics
Network with experts and leading drug developers, regulators and investors in the industry

Who you will meet: Chief Executives, Executive Directors, Vice Presidents, Head Team Leaders and Managers working within:

Follow on Biologics/Follow on Proteins/Biosimilars
Biologics/Biotechnology/ Biogenerics
Biopharmaceuticals / Biotherapeutics
Legal and Regulatory Affairs
Intellectual property
Pricing and Reimbursement
Clinical Immunology
R&D
New Product Development
Quality Affairs/ Quality Control
Principal Scientist
Pharmacovigilance
Chief Scientific Officer
Drug Safety & Risk Management
Process Control and Analytical Technologies
Business Development and Market Strategies
Commercial Affairs
Legislation and Policy Advice
Licensing
Manufacturing and APIs.